Atlas Trials

Alaunos Therapeutics

37 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Alaunos Therapeutics

RecordFirmDate
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs (NCT05292859)Alaunos Therapeutics2023-03-01
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors (NCT05194735)Alaunos Therapeutics2022-04-04
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors (NCT05124743)Alaunos Therapeutics2021-09-24
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma (NCT04006119)Alaunos Therapeutics2019-08-01
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102 (NCT03679754)Alaunos Therapeutics2018-09-05
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102 (NCT03636477)Alaunos Therapeutics2018-06-18
A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG (NCT03330197)Alaunos Therapeutics2017-09-26

Track Alaunos Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.